CARDIAC MARKER TESTING DEVICES MARKET ANALYSIS

Cardiac Marker Testing Devices Market, By Marker Type (Lactate Dehydrogenase, Creatine Kinase, and Myoglobin), By Product Type (Instruments, and Reagents and Kits), By Application (Acute Coronary Syndrome, Myocardial Infraction, and Cardiac Heart Failure), By Testing Type (Laboratory and Point-of-care), and By End User (Hospitals, Diagnostic Laboratory, and Home Care Setting) - Global Industry Insights, Trends, Outlook and Opportunity Analysis, 2022-2028

Key Development in Cardiac Marker Testing Devices Market

In September 2019, Sanskritech Smart Solutions Pvt Ltd launched a self-monitoring health diagnostic Point of Care Testing (POCT) system ‘Swayam AHM’. The device can perform 55 basic and advanced tests including cardiac marker, hormone marker, blood-borne disease and other POC tests.
In September 2019, Hangzhou AllTest Biotech CO., LTD launched its Cardiac troponin T (cTnT) rapid test for the detection of the cardiac marker
In May 2016, Royal Philips launched handheld blood test, the Minicare I-20 system, for rapid diagnosis of a heart attack at the point of care. The devices measures the level of cardiac troponin I (cTnI), a protein excreted by the heart muscle into the blood following a heart attack.
In November 2016, Abbott received CE marking for its i-STAT Alinity System, an innovative handheld blood testing platform. The device is designed to perform and analyze the blood tests on a single device, ranging from blood chemistries to cardiac markers.